{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:00:44Z","timestamp":1790103644380,"version":"4.0.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Evidence regarding statin therapy in non-acute myocardial infarction cardiogenic shock is limited, and retrospective medication studies are vulnerable to treatment-timing bias. We examined whether the association between statin exposure and 28-day mortality persisted after accounting for the timing of statin administration. This retrospective cohort study used medical information mart for intensive care IV data from 991 adults with non-acute myocardial infarction cardiogenic shock. Statin exposure was ascertained from medication records that included atorvastatin and other statin agents. In the conventional time-fixed analysis, exposure was defined as receipt of any statin during the intensive care unit (ICU) stay. A 24-hour landmark analysis included patients alive at 24 hours, classified exposure according to statin administration during the 1st 24 hours, and began follow-up at the landmark. Separate 1:1 propensity-score matching (PSM) procedures and Cox models were performed for each exposure definition. Statin agent, 1st recorded dose, route, and time to 1st administration, together with specific mechanical-support, anti-inflammatory, and vasoactive co-treatments, were descriptively summarized in the matched cohorts. In the conventional cohort, 475 patients received a statin during the ICU stay and 516 did not; 255 patients per group remained after PSM. Conventional analyses suggested lower 28-day mortality before matching (adjusted hazard ratio [HR], 0.703; 95% confidence interval [CI], 0.539\u20130.918;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.010) and after PSM (adjusted HR, 0.709; 95% CI, 0.507\u20130.993;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.045). In the 24-hour landmark cohort, 311 patients received a statin within 24 hours and 680 did not; 255 patients per group remained after PSM. The association was absent before matching (adjusted HR, 1.127; 95% CI, 0.854\u20131.487;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.398) and after PSM (adjusted HR, 1.190; 95% CI, 0.833\u20131.701;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.339). Atorvastatin was the predominant 1st statin in both matched exposed groups. In 4-category analyses, the apparent benefit among new initiators in conventional models disappeared after the 24-hour landmark definition was applied. The apparent survival advantage associated with conventional time-fixed statin exposure was not reproduced after treatment timing was addressed. These findings do not support an independent 28-day survival benefit from statin administration within the 1st 24 hours of ICU admission and highlight the potential influence of immortal-time, treatment-selection, and co-treatment biases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050754","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:38Z","timestamp":1789750898000},"page":"e50754","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Statin use and 28-day survival in critically ill patients with non-acute myocardial infarction cardiogenic shock"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4713-4662","authenticated-orcid":false,"given":"Tonghui","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panji","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Intensive Care Unit, Luohe Central Hospital, Luohe, Henan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-175X","authenticated-orcid":false,"given":"Hailong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019.","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13613-024-01260-y","article-title":"Management of cardiogenic shock: a narrative review.","volume":"14","author":"Laghlam","year":"2024","journal-title":"Ann Intensive Care"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00134-024-07618-x","article-title":"Management of cardiogenic shock: state-of-the-art.","volume":"50","author":"Jung","year":"2024","journal-title":"Intensive Care Med"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review.","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/ehf2.15046","article-title":"Clinical profile, short and long-term outcomes of non-ischaemic cardiogenic shock: a FRENSHOCK sub-analysis.","volume":"12","author":"Cherbi","year":"2025","journal-title":"ESC Heart Fail"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3390\/biomedicines12092073","article-title":"The role of inflammation in the pathogenesis of cardiogenic shock secondary to acute myocardial infarction: a narrative review.","volume":"12","author":"Kologrivova","year":"2024","journal-title":"Biomedicines"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins.","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol Ther"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4244\/EIJV6I3A58","article-title":"Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock.","volume":"6","author":"Garot","year":"2010","journal-title":"EuroIntervention"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.ijcard.2013.07.036","article-title":"Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.","volume":"168","author":"Liao","year":"2013","journal-title":"Int J Cardiol"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/eurheartj\/ehs005","article-title":"Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials.","volume":"33","author":"Rahimi","year":"2012","journal-title":"Eur Heart J"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/jcm9040931","article-title":"Patient characteristics, treatment and outcome in non-ischemic vs. ischemic cardiogenic shock.","volume":"9","author":"Schrage","year":"2020","journal-title":"J Clin Med"},{"key":"R13-20260922","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease.","volume":"2013","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.","volume":"340","author":"Levesque","year":"2010","journal-title":"BMJ"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point.","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset.","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance.","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference.","volume":"15","author":"Ho","year":"2007","journal-title":"Polit Anal"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward.","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MCA.0000000000000776","article-title":"The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock.","volume":"30","author":"Cinar","year":"2019","journal-title":"Coron Artery Dis"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hlc.2017.10.023","article-title":"Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction complicated with cardiogenic shock.","volume":"28","author":"Hayiroglu","year":"2019","journal-title":"Heart Lung Circ"},{"key":"R25-20260922","first-page":"10","article-title":"Clinical characteristics and outcomes of acute coronary syndrome patients with intra-aortic balloon pump inserted in intensive cardiac care unit of a tertiary clinic.","volume":"46","author":"Hayiroglu","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MCA.0000000000001219","article-title":"Prognostic value of intermountain risk score for short- and long-term mortality in patients with cardiogenic shock.","volume":"34","author":"Hayiroglu","year":"2023","journal-title":"Coron Artery Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:17Z","timestamp":1790100197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050754"}},"subtitle":["A retrospective cohort study accounting for treatment timing"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":26,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050754","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2026-05-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}